Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.
The business is unprofitable at the operating level (-3551.75% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 24424.0% YoY with margins expanding 34157.1pp.
ROIC dropped from -4.08% to -137.11%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
€384K
▲ +24424.0% YoY
Net Income (TTM)
-€19M
▼ -3244.1% YoY
Op. Margin
-3551.75%
▲ +34157.1pp YoY
ROIC
-137.11%
▼ -133.0pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow
N/A
Net Debt
€3M
Cash & Equiv.
€958.00
3Y CAGR: +36.6%
Continue Research